News

New Research Leverages AI/ML and Sensor Technologies

AI-driven advances in clinical motion analysis helps grow the body of evidence on the efficacy of activity-based therapies for Parkinson’s disease.

HealthIT Answers

March 14, 2024

Bringing Physical Therapy Home with the Help of AI and RTM

Technological innovations are allowing a growing number of healthcare services to be provided in the patient’s home, including remote therapeutic monitoring (RTM). AI is changing the healthcare paradigm with real-time, clinically relevant medical technology that evaluates patient performance, improves patient adherence, and increases clinician access. It also improves the medical economics of treating a wide variety of pathologies. AI-driven, in-home care, under the watchful eye of one’s physical therapist, has been significantly enhanced by bringing together easy-to-use mobile applications, connected devices, data analysis, patients, practitioners, and payers.

PT Products Magazine

March 12, 2024

Motion sensors confirm boxing may help ease Parkinson’s disease symptoms is some patients

ATLANTA, GA, Nov 1, 2023 (FOX 5 Atlanta) – Does boxing really help with Parkinson’s? Across Georgia, people living with Parkinson’s Disease are turning to exercise to help manage their symptoms. One of the most popular options is non-contact boxing. A new study using high-tech movement sensors shows the sport may help improve balance and walking for patients.Since his diagnosis with Parkinson’s disease in 2019, Brian Soucy has been doing everything he can to maintain his balance and core strength.

FOX 5 Atlanta

November 1, 2023

BioMech Health Wins Leading Specialists in Healthcare Real-Time Motion Analytics in the GHP Healthcare and Pharma Awards 2023

RICHMOND, VA, Sept. 26, 2023 (GLOBE NEWSWIRE) — BioMech Health, LLC, a division of BioMech Holdings, LLC, today announced that it has been selected the winner of “Leading Specialists in Healthcare Real-time Motion Analytics” in the 2023 Global Health & Pharma Healthcare and Pharmaceutical Awards. The award recognizes BioMech’s artificial intelligence engine, Coretex.AI, and BioMech Lab, which allows patients and clinicians to quantitatively measure and monitor patients’ functional motion including balance, gait and range of motion in clinic and at home to determine appropriate treatment and assess progress to improve recovery, transforming the way healthcare is delivered.

BioMech

September 26, 2023

Road to recovery: Groundbreaking A.I. is helping injured Georgia truck driver get back in the seat

ATLANTA, GA – JULY 26, 2023 – BioMech Lab uses state-of-the-art tech. to empower both doctors and patients. After suffering a bad fall, longtime truck driver and Georgia resident Robert Stahl found himself facing a post-concussion syndrome diagnosis. He couldn’t talk and could barely walk at the time, but that’s all changed now. Thanks to a potentially groundbreaking state-of-the-art medical technology that utilizes artificial intelligence, Stahl is well on the road to recovery.

Hunter Boyce

July 26, 2023

BioMech Holdings LLC Appoints Athanassios Diplas to its Board of Directors

RICHMOND, VA – April 13, 2023 – BioMech Holdings, LLC, which develops and distributes real-time motion analytics that quantify and improve patient outcomes in the healthcare, sports, wellness, and industrial sectors, is announcing the appointment of Athanassios Diplas, PhD to its board of directors. In his capacity, Diplas will act in an advisory role, utilizing vast experience in global finance and science to provide strategic counsel as BioMech expands into diverse markets.

BioMech

April 13, 2023

Can Doctors Objectively Quantify and Measure Pain? The Future of Pain Management

Millions of Americans live with acute and chronic pain that affects every aspect of their lives. Pain by itself is an important marker of how a patient is feeling and indicates what kind of medical intervention might be necessary. The healthcare industry needs a clinically acceptable way to objectively measure pain and since pain is a very complex mixture of biochemistry and genetics and it’s unlikely that a laboratory test that directly quantifies pain will be developed.

BioMech

November 18, 2022

BioMech Lab Wins Most Advanced Clinical Motion Assessment Tool in the 2022 GHP Fitness & Nutrition Awards

Award recognizes BioMech Lab™ for its use of motion as a functional biomarker to quantify relevant aspects of physical, surgical, pharmaco and cognitive therapies.

BioMech

October 26, 2022

The focus of the internet of things (IoT)

In many ways, internet of things (IoT) is a double-edged sword: connected devices are capturing huge volumes and varieties of data that can be mined for everything from potentially life-saving health care information to guidance toward peak athletic performance, but it is incredibly difficult to convert that raw data into truly meaningful and actionable insights.

BioMech

October 9, 2022

‘Laboratory For Motion’ Uses AI To Turn Movements Into Clinical Endpoints

Movement can now be used as a functional biomarker and endpoint for all sorts of treatments—including orthopedic surgery for bad knees and hips, spinal cord stimulation for debilitating back pain, weight-loss programs for obesity, and even laser surgery for glaucoma. Physicians are really all rehabilitative medicine specialists whose goal is to get patients to move better, according to Frank Fornari, Ph.D., chairman and founder of BioMech Holdings, LLC, which has created a clinically relevant “laboratory for motion.”

Deborah Borfitz

August 25, 2022

The Predictive Power of Functional Motion

Motion is fundamental to health. When the ability to move is lost, so too is the ability for the human body to function as intended. In fact, every single movement the body makes is predicated on a pathological state that is as unique as a fingerprint, making motion a powerful indicator of a wide array of health issues.

BioMech

August 1, 2022

Eraj Shirvani Appointed to Board of Directors for BioMech Holdings LLC

RICHMOND, VA – July 12, 2022 – Richmond, VA (July 12 , 2022) – BioMech Holdings, LLC, which develops and distributes real-time motion analytics that quantify and improve patient outcomes in the healthcare, sports, wellness, and industrial sectors, is announcing the appointment of Eraj Shirvani, Chairman – Emerging Markets at Credit Suisse, to its board of directors. In this capacity, Shirvani will act in an advisory role, utilizing his vast experience in global finance to provide strategic counsel as BioMech expands into diverse markets.

BioMech

July 12, 2022

BioMech Wins Best Overall Biometric Solution

Award recognizes BioMech Lab™ for its use of motion as a functional biomarker to quantify relevant aspects of physical, surgical, pharmaco and cognitive therapies.

BioMech

June 29, 2022

BioMech, ēlizur Announce Partnership

Integrating BioMech Lab™ into the SSS shoulder device delivers automated functional motion data collection and analysis to measure therapeutic progress.

BioMech

June 22, 2022

The Transformative Power of AI and ML

Artificial intelligence (AI) and machine learning (ML) are transforming the practice of medicine, enabling significant amounts of patient data to be converted and returned to clinicians as actionable and clinically relevant information, guiding diagnoses and treatment decisions. Now, AI/ML are bringing to healthcare a complex, yet powerful, indicator of health: functional motion.

HealthIT Answers

May 31, 2022

Optimizing Care Outcomes

Functional motion is a powerful indicator of health, and its restoration is the primary desired outcome across many medical disciplines. The ability to assess any sudden or gradual change in motion can be an important part of early diagnosis and treatment of a wide array of health issues. That is why demand is growing for clinically actionable and objective functional motion data that can guide, demonstrate, and evaluate the efficacy of diagnosis and treatment. Utilizing artificial intelligence (AI), machine learning (ML), mobile technologies, and real-time interactive biofeedback makes it possible to capture motion data in clinical or real-world settings and deliver precise, accurate and reproducible therapeutic assessments and treatments that stratify risk, improve outcomes, and increase the efficiency of the healthcare delivery system.

HealthCare Business News (HCB News)

April 29, 2022

Health Tech: Frank Fornari On How BioMech’s Technology Can Make An Important Impact On Our Overall Wellness

Make it accessible and affordable to EVERYONE: My focus has always been on making things that are accessible and affordable for everyone. For example, we used to design therapeutic drugs. It does me no good to make a cancer drug that costs $30,000 per pill, because that’s only going to help a few people. It doesn’t move the needle on cancer. We try to build everything in a way that makes our technology and therefore science affordable, scalable, and accessible. Corporations may not always feel that way, but the people on the bench, the scientists, don’t go into this saying ‘let’s make this the most expensive treatment we can make.’ That’s not even a thought for anybody who does this for a living.

BioMech

March 20, 2022

BioMech Sets New Standard of Care with AI-enabled, Clinically Actionable Real-time Motion Analytics for Improved Healthcare Outcomes

RICHMOND, Va., Feb. 8, 2022 /PRNewswire/ — Responding to growing demand for clinically actionable, quantifiable data to both guide and demonstrate the efficacy of treatment decisions, BioMech Health, a division of BioMech Holdings, LLC, has launched BioMech Lab™ to arm clinicians with the ability to capture – in real-time – the relevant motion metrics necessary to rapidly evaluate, design and monitor physical, surgical, pharmaco and cognitive therapies. Coupling advanced sensor technology with powerful artificial intelligence (AI) and machine learning (ML) algorithms and interactive biofeedback, BioMech Lab captures motion data in clinical or real-world settings to deliver precise, accurate and reproducible assessments and treatment modifications that stratify risk and improve care outcomes.

BioMech

February 8, 2022